Skip to main content
. 2022 Jun 2;13:879452. doi: 10.3389/fimmu.2022.879452

Table 4.

Therapeutic response after HAIC and VAX-NK/HCC therapy (n = 11).

Number of patients (%)
Best overall response
Complete response 4 (36.4)
Partial response 3 (27.3)
Stable disease 2 (18.2)
Progressive disease 2 (18.2)
Objective response rate 7 (63.6)
Disease control rate 9 (81.8)

HAIC, hepatic arterial infusion chemotherapy; HCC, hepatocellular carcinoma; NK, natural killer.